PAP
RNAM

Persistent Asset Partners’s Avidity Biosciences RNAM Stock Holding History

Persistent Asset Partners’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-839
Closed -$1.48M – 451
2025
Q4 		$1.48M Buy
839
+381
+83% +$24.6K 0.66% 34
2025
Q3 		$504K Buy
+458
New +$18.5K 0.35% 87

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Persistent Asset Partners's RNAM Position: Q4 2025 in Review

Persistent Asset Partners sold out of Avidity Biosciences (RNAM) in Q4 2025, closing a stake of 6,864 shares — an estimated $443K sold.

Persistent Asset Partners first reported a position in RNAM in Q3 2025 and held it in 1 quarter. The position peaked at $299K in Q3 2025. 343 funds tracked by Wall St. Rank hold RNAM as of Q4 2025.

  • Persistent Asset Partners reported no remaining Avidity Biosciences position as of Q4 2025 after selling out during the quarter.
  • Persistent Asset Partners sold 6,864 Avidity Biosciences shares in Q4 2025, an estimated $443K.
  • Persistent Asset Partners first reported a position in Avidity Biosciences in Q3 2025 and held it in 1 quarter.
  • Persistent Asset Partners's Avidity Biosciences position peaked at $299K in Q3 2025.
  • 343 funds tracked by Wall St. Rank held Avidity Biosciences as of Q4 2025.

Based on Persistent Asset Partners's 13F filing for Q4 2025, filed 17 Feb 2026.